Pancreatic Cancer Basics
598 articles
Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer
A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.
The Pancreatic Standard of Care is No Longer So Standard
Do you want to understand more about how your doctor chooses your treatments? Learn about the standard of care for pancreatic cancer.
Finding More Clues about Circulating Tumor DNA
Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.
Let’s Win Pancreatic Cancer Launches Updated Spanish Platform
Let’s Win is proud to announce the launch of it’s updated Spanish platform, with all the new features of the updated English platform.
Risk Factors and Symptoms of Pancreatic Cancer
In this webinar oncologist Dr. Shaalan Beg outlines pancreatic cancer risk factors and gastroenterologist Dr. Oscar Alvarez explains how he looks at symptoms.
Damage as a Way to Repair Pancreatic Cancer
Dr. Talia Golan takes a closer look at the damage caused by the BRCA1/2 mutations to find a way to treat pancreatic cancer.
A New Drug Combination to Control Advanced Pancreatic Cancer
A clinical trial for pancreatic cancer patients with the BRCA mutation tests the effectiveness of standard treatment plus a PARP inhibitor.
Access and Disparities in Pancreatic Cancer Surgery Remain Pervasive Problems
Dr. Susan Tsai discusses her research into the causes of pancreatic cancer surgery and treatment disparities for underserved communities.
Inhibiting Cell Division With Alternating Electric Fields
Dr. Andrew Coveler explains how electric fields are being used to disrupt pancreatic cancer cell division, to make tumors more removable.